TY - JOUR
T1 - Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease.
AU - Moons, Philip
AU - Luyckx, Koen
AU - Luyckx, Koen
AU - Kovacs, Adrienne H.
AU - Kovacs, Adrienne H.
AU - Holbein, Christina E.
AU - Thomet, Corina
AU - Thomet, Corina
AU - Budts, Werner
AU - Enomoto, Junko
AU - Sluman, Maayke A.
AU - Sluman, Maayke A.
AU - Yang, Hsiao-Ling
AU - Jackson, Jamie L.
AU - Khairy, Paul
AU - Cook, Stephen. C.
AU - Chidambarathanu, Shanthi
AU - Alday, Luis Eduardo
AU - Eriksen, Katrine
AU - Dellborg, Mikael
AU - Dellborg, Mikael
AU - Berghammer, Malin
AU - Berghammer, Malin
AU - Berghammer, Malin
AU - Johansson, Bengt Erik
AU - Mackie, Andrew S.
AU - Menahem, Samuel A.
AU - Caruana, Maryanne
AU - Veldtman, Gruschen R.
AU - Soufi, Alexandra
AU - Fernandes, Susan M.
AU - White, Kamila S.
AU - Callus, Edward
AU - Kutty, Shelby
AU - Kutty, Shelby
AU - Apers, Silke
PY - 2019/8/14
Y1 - 2019/8/14
N2 - Background The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.
AB - Background The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.
UR - https://www.onlinecjc.ca/article/S0828-282X(19)31150-X/fulltext
U2 - 10.1016/J.CJCA.2019.07.635
DO - 10.1016/J.CJCA.2019.07.635
M3 - Article
VL - 35
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
ER -